Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- GBX | -.--% | -47.06% | -.--% |
2019 | SalvaRx Evaluates Takeover Opportunities | CI |
2019 | Salvarx Group plc Reports Earnings Results for the Half Year Ended June 30, 2019 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
2.16M | - | - | - | - | - | |
115B | ||||||
106B | ||||||
24.69B | - | |||||
21.97B | - | |||||
19.27B |
- Stock Market
- Equities
- SALV Stock
- Charts SalvaRx Group plc
- Sector Chart